San Francisco based AI startup LuminAI has closed a $38 million Series B funding round led by Peak XV Partners and simultaneously announced a strategic enterprise partnership with Cleveland Clinic to deploy its AI-native platform for automating complex administrative workflows across the renowned health system.
Glimpse:
The funding, announced around April 9–10, 2026, brings LuminAI’s total capital raised to $60 million, with participation from Define Ventures and existing backers General Catalyst and Y Combinator. The Cleveland Clinic collaboration focuses on using LuminAI’s platform to process unstructured data, automate end to end processes such as referral management, and reduce administrative burdens so clinicians can spend more time on patient care. The platform has already delivered over 12 million automations with an average time to value of just 48 days.
LuminAI, an emerging San Francisco-based startup specializing in AI-driven automation for healthcare operations, has successfully raised $38 million in a Series B funding round. Led by Peak XV Partners, the round also saw participation from new investor Define Ventures along with continued support from existing investors General Catalyst and Y Combinator. This fresh capital brings the company’s total funding to $60 million and will fuel product expansion, team growth in engineering and deployment, and deeper support for its expanding customer base.
At the same time, LuminAI announced a significant enterprise partnership with Cleveland Clinic, one of the largest and most respected health systems in the United States. The collaboration involves deploying LuminAI’s intelligent platform to optimize operational workflows across the clinic’s network. The AI solution is specifically designed to handle fragmented and unstructured data sources such as faxes and documents interpret operational context, and execute complete end-to-end workflows in areas like patient access, revenue cycle management, compliance, and referrals
Unlike traditional point solutions that address only isolated tasks, LuminAI’s platform acts as a unified AI-native system that learns from real operational conditions and continuously improves. Early results from customers show strong performance, with more than 12 million automations completed and an average return on investment achieved within just 48 days. For Cleveland Clinic, which serves millions of patients annually, the initial focus includes intelligent routing of complex referrals, aiming to cut administrative workload and allow healthcare professionals to concentrate more on direct patient care.
This dual announcement underscores the growing demand for enterprise grade AI that can tackle the massive coordination challenges in large health systems without requiring major infrastructure overhauls. The funding and partnership together position LuminAI to scale its impact and help address the estimated trillion dollar burden of administrative costs in healthcare.
“Healthcare’s administrative functions operate as a massive, manual coordination layer. Recent advances in AI have made it possible to handle that complexity directly and execute full workflows reliably. LuminAI is building an AI-native platform designed for the realities of large health systems, one that learns from operational context and improves as conditions evolve. This round enables us to scale that foundation to meet the growing demand of our health system partners.”
By
HB Team
Related News
